The overall selection process is illustrated in a PRISMA-ScR flowchart detailing the number of records identified, screened, excluded (with reasons), and included in the review
Persistent markedly low serum potassium (less than 3 mEq/L, and a reduction from pre-treatment of greater than 0.5 mEq/L at two consecutive visits or at the final visit) occurred in 0.2% receiving QSYMIA 7.5 mg/46 mg dose and 0.1% receiving QSYMIA 15 mg/92 mg dose, compared to 0.0% receiving placebo
concerns about budget impact of covering AOMs, estimated by CMS to cost federal and state governments $40Bn over a decade
Hims & Hers projects 2024 revenue to hit $1.37B buoyed by demand for weight loss drugs, Fierce Healthcare, August 6, 2024
Driving to a weight management clinic isnt realistic
If you have been on tirzepatide for months and your weight loss has stalled , some providers consider adding phentermine as a short-term boost rather than immediately increasing the tirzepatide dose